126 related articles for article (PubMed ID: 23665420)
1. Ultrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancer.
Palantavida S; Guz NV; Woodworth CD; Sokolov I
Nanomedicine; 2013 Nov; 9(8):1255-62. PubMed ID: 23665420
[TBL] [Abstract][Full Text] [Related]
2. Ultrabright fluorescent silica nanoparticles for in vivo targeting of xenografted human tumors and cancer cells in zebrafish.
Peerzade SAMA; Qin X; Laroche FJF; Palantavida S; Dokukin M; Peng B; Feng H; Sokolov I
Nanoscale; 2019 Nov; 11(46):22316-22327. PubMed ID: 31724677
[TBL] [Abstract][Full Text] [Related]
3. Ultrabright fluorescent mesoporous silica nanoparticles.
Cho EB; Volkov DO; Sokolov I
Small; 2010 Oct; 6(20):2314-9. PubMed ID: 20859948
[TBL] [Abstract][Full Text] [Related]
4. Detection of cancerous cervical cells using physical adhesion of fluorescent silica particles and centripetal force.
Gaikwad RM; Dokukin ME; Iyer KS; Woodworth CD; Volkov DO; Sokolov I
Analyst; 2011 Apr; 136(7):1502-6. PubMed ID: 21305062
[TBL] [Abstract][Full Text] [Related]
5. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
6. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
7. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
8. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
[TBL] [Abstract][Full Text] [Related]
10. [Cervical cancer screening: past--present--future].
Breitenecker G
Pathologe; 2009 Dec; 30 Suppl 2():128-35. PubMed ID: 19756616
[TBL] [Abstract][Full Text] [Related]
11. Cervical screening in HPV-vaccinated populations.
Canfell K
Climacteric; 2018 Jun; 21(3):227-234. PubMed ID: 29565690
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy detection for diagnostic and prognostic use in premalignant and malignant lesions of the uterine cervix: A systematic review.
Costa AF; Ribeiro MGM; Onofre ASC; de Miranda Onofre FB
Diagn Cytopathol; 2021 Feb; 49(2):335-346. PubMed ID: 33332763
[TBL] [Abstract][Full Text] [Related]
13. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
14. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.
Ritter DB; Kadish AS; Vermund SH; Romney SL; Villari D; Burk RD
Am J Obstet Gynecol; 1988 Dec; 159(6):1517-25. PubMed ID: 2849881
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-functionalized mesoporous silica nanospheres hybridized with AIE luminogens for targeted cancer cell imaging.
Wang Z; Xu B; Zhang L; Zhang J; Ma T; Zhang J; Fu X; Tian W
Nanoscale; 2013 Mar; 5(5):2065-72. PubMed ID: 23376958
[TBL] [Abstract][Full Text] [Related]
16. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus infection status of single cells isolated from cervical cytology specimens by simple manual microdissection.
Noji N; Okayama K; Oda M; Shimada A; Okodo M
J Med Virol; 2021 Aug; 93(8):5084-5094. PubMed ID: 33599297
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
19. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
[TBL] [Abstract][Full Text] [Related]
20. Comparative Study of Cytology and Histopathology of Cervical Lesion in VIA Positive Patients and Its Correlation with High Risk Human Papilloma Virus.
Ansari NP; Saleh FM; Shahida SM; Rahman EN
Mymensingh Med J; 2017 Jul; 26(3):505-513. PubMed ID: 28919602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
